205 related articles for article (PubMed ID: 18166768)
1. Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report.
Meuleman N; Vanhaelen G; Tondreau T; Lewalle P; Kwan J; Bennani J; Martiat P; Lagneaux L; Bron D
Haematologica; 2008 Jan; 93(1):e11-3. PubMed ID: 18166768
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).
Koç ON; Day J; Nieder M; Gerson SL; Lazarus HM; Krivit W
Bone Marrow Transplant; 2002 Aug; 30(4):215-22. PubMed ID: 12203137
[TBL] [Abstract][Full Text] [Related]
3. Reply to: Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report. Haematologica 2008; 93:e11-13.
Charnas L; Eichler F; Kohlschuetter A; Tolar J; Orchard PJ
Haematologica; 2008 May; 93(5):e47; author reply e48. PubMed ID: 18450730
[No Abstract] [Full Text] [Related]
4. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
[TBL] [Abstract][Full Text] [Related]
5. In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients.
Müller I; Kustermann-Kuhn B; Holzwarth C; Isensee G; Vaegler M; Harzer K; Krägeloh-Mann I; Handgretinger R; Bruchelt G
Exp Hematol; 2006 Oct; 34(10):1413-9. PubMed ID: 16982334
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic Stem Cell Transplantation with Mesenchymal Stromal Cells in Children with Metachromatic Leukodystrophy.
Cabanillas Stanchi KM; Böhringer J; Strölin M; Groeschel S; Lenglinger K; Treuner C; Kehrer C; Laugwitz L; Bevot A; Kaiser N; Schumm M; Lang P; Handgretinger R; Krägeloh-Mann I; Müller I; Döring M
Stem Cells Dev; 2022 Apr; 31(7-8):163-175. PubMed ID: 35323019
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
8. Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen.
Resnick IB; Abdul Hai A; Shapira MY; Bitan M; Hershkovitz E; Schwartz A; Ben-Harush M; Or R; Slavin S; Kapelushnik J
Clin Transplant; 2005 Dec; 19(6):840-7. PubMed ID: 16313334
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of juvenile metachromatic leukodystrophy after bone marrow transplantation: a 13-year follow-up.
Görg M; Wilck W; Granitzny B; Suerken A; Lukacs Z; Ding X; Schulte-Markwort M; Kohlschütter A
J Child Neurol; 2007 Sep; 22(9):1139-42. PubMed ID: 17890417
[TBL] [Abstract][Full Text] [Related]
10. Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis.
Statkute L; Oyama Y; Barr WG; Sufit R; Ho S; Verda L; Loh Y; Yaung K; Quigley K; Burt RK
Ann Rheum Dis; 2008 Jul; 67(7):991-7. PubMed ID: 17947303
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
Huisman C; Meijer E; Petersen EJ; Lokhorst HM; Verdonck LF
Biol Blood Marrow Transplant; 2008 Feb; 14(2):181-6. PubMed ID: 18215778
[TBL] [Abstract][Full Text] [Related]
12. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
Turner BE; Kambouris ME; Sinfield L; Lange J; Burns AM; Lourie R; Atkinson K; Hart DN; Munster DJ; Rice AM
Transplantation; 2008 Oct; 86(7):968-76. PubMed ID: 18852664
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.
Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T
Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells and haematopoietic stem cell transplantation.
Bacigalupo A
Best Pract Res Clin Haematol; 2004 Sep; 17(3):387-99. PubMed ID: 15498711
[TBL] [Abstract][Full Text] [Related]
16. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
Müller I; Kordowich S; Holzwarth C; Isensee G; Lang P; Neunhoeffer F; Dominici M; Greil J; Handgretinger R
Blood Cells Mol Dis; 2008; 40(1):25-32. PubMed ID: 17869550
[TBL] [Abstract][Full Text] [Related]
17. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
Gonzalo-Daganzo R; Regidor C; Martín-Donaire T; Rico MA; Bautista G; Krsnik I; Forés R; Ojeda E; Sanjuán I; García-Marco JA; Navarro B; Gil S; Sánchez R; Panadero N; Gutiérrez Y; García-Berciano M; Pérez N; Millán I; Cabrera R; Fernández MN
Cytotherapy; 2009; 11(3):278-88. PubMed ID: 19308773
[TBL] [Abstract][Full Text] [Related]
18. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of haematopoietic stem cell transplantation for inherited metabolic disorders: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry.
Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw PJ; Teague L; Fraser CJ; Carter TL; Tapp H; Alvaro F; O'Brien TA
Pediatr Transplant; 2013 Sep; 17(6):582-8. PubMed ID: 23802616
[TBL] [Abstract][Full Text] [Related]
20. Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome.
Gozdzik J; Czogala W; Skoczen S; Krasowska-Kwiecien A; Wiecha O; Mordel A; Lesko E; Majka M; Kowalczyk D; Zembala M
Pediatr Transplant; 2009 Sep; 13(6):760-5. PubMed ID: 18992055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
